Shares of biotech Summit Therapeutics ( SMMT 9.31%) skyrocketed 583.7% in 2024, according to data from S&P Global Market ...

The Food and Drug Administration (FDA) has issued a “Dear Veterinarian Letter” regarding reports of adverse events in dogs ...

The FDA has narrowly beaten the European Medicines Agency (EMA) to the most approved drugs with a new active substance in ...

A new storage technique can keep protein-based drugs and vaccines stable without keeping them cold. The discovery, led by ...

Monoclonal Antibody to Inhibit IL33 for Autoimmune Disorders is under clinical development by Eli Lilly and Co and currently in Phase I for Autoimmune Disorders.

According to Inan’s team: “There is no documented production process of atezolizumab biosimilar in the literature except one ...

According to a cross-sectional study, mothers who took antidepressants or anti-inflammatory medications had lower levels of ...

The market will grow as a result of the increasing incidence of amyloidosis, technological advancements in diagnostics, ...

General Manager and CEO of Junshi Biosciences, Dr. Jianjun ZOU, said, “Toripalimab has made significant strides in its internationalization. As of today, toripalimab has been approved in 35 countries ...

Current treatments for dermatomyositis include various immunosuppressants and immunosuppressive agents, including ...

AstraZeneca Pharma India rose 1.10% to Rs 10,754 after the firm received approval from the Central Drugs Standard Control Organisation (CDSCO) to import pharmaceutical formulations of eculizumab ...

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to GSK5764227 (GSK’227) for the treatment of adult patients with relapsed or refractory (R/R) osteosarcoma who have ...